Hengtong Co., Ltd. stated at the 2026 third quarter results briefing that the company will continue to promote internal collaboration and resource integration in the biotechnology business sector based on existing business, give full play to synergy effects and enhance the overall competitiveness of the existing product line. Furthermore, the company will also actively pay attention to technology and product opportunities in external segments, conduct careful assessments around key links in the industrial chain and emerging technology directions, and take the opportunity to improve the industrial layout through cooperation and investment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.